Women were less than half of the people tested for almost all of these common medicines.

Blood pressure & heart rhythm

metoprolol

Women can get higher levels in their blood from the same dose, yet fewer than 2% of its studies looked at women's results separately.

  • 41.6%

    of the people in the studies were women

  • 46%

    of studies did not allow pregnant women

  • 2%

    looked at results for women separately

Was someone like me tested?

Choose the group that fits you.

Not one of these studies reported results separately for any of the groups below.

Not studied

Pregnant women

46% of studies would not let pregnant women join, and we found no study that tested this medicine in pregnancy.

What do we know?

What the FDA drug label says

Studies that followed pregnant women have not linked it to problems for the baby. Uncontrolled high blood pressure in pregnancy is risky in itself.

Good to know

Women tend to reach higher blood levels of metoprolol than men on the same dose, but the dose is the same for everyone.

What women report more

Compared with men taking the same medicine.

  • 2.7Γ—Food intolerance
  • 2.0Γ—Changes to the front of the eye
  • 1.9Γ—Broken bones
  • 1.9Γ—Hair, nail and sweat-gland problems

How many times more often women reported each problem than men taking the same medicine, based on reports to the FDA. This is a warning sign, not proof the medicine caused it.

Make it about you

Check it against your medicines

Check metoprolol against the medicines, pregnancy and birth control in your profile.

Join to check

Women's experiences

Join or sign in to share, like or save. You'll fill in a short health profile so your story has context and we can check your medicines.

No one has shared yet. Your story could help the next woman.

All the details

Every number behind this page.

Who was in the studies

18,934 people in 58 studies

7,882 womenmiddle line = equal numbers11,052 men

Race

  • White91.5%
  • Black / African American7.2%
  • Other0.4%
  • Asian0.4%
  • Hispanic / Latina0.1%

Studies didn't say how many of the women were Black, Asian or another race β€” only totals for everyone.

Hispanic or Latina
7.2%
Age 65 or older
31.2%
Studies with men only
1
Studies with women only
3
Rules that kept women out

Share of studies with each rule.

  • 66%

    No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    See the exact rule
    β€œKnown cardiovascular disease (including history of angina pectoris, heart failure, presence of a cardiac pacemaker, history of myocardial infarction or revascularization procedure, or cerebrovascular disease, including stroke and TIA)” NCT01203852
  • 46%

    No pregnant women

    Women who were pregnant could not join.

    See the exact rule
    β€œPregnancy or lactation” NCT01203852
  • 34%

    No diabetes

    Women with diabetes were turned away.

    See the exact rule
    β€œDiabetes mellitus (Type 1 or 2)” NCT01203852
  • 24%

    No mental health conditions

    Women with depression, bipolar disorder or other mental health conditions were turned away.

    See the exact rule
    β€œA serious physician-recorded psychiatric morbidity that would interfere with the study” NCT00241904
  • 20%

    No breastfeeding moms

    Women who were breastfeeding could not join.

    See the exact rule
    β€œPregnancy or lactation” NCT01203852
  • 20%

    Only women past menopause

    Women who could still get pregnant were turned away.

    See the exact rule
    β€œMust be postmenopausal or taking some form of birth control of surgically sterile” NCT00829296
What nobody checked

Share of studies that recorded each thing.

  • 2%
    Results shown separately for women
  • 0%
    Whether anyone was pregnant
  • 0%
    Whether women were past menopause
  • 9%
    Body weight (BMI)
  • 31%
    Hispanic / Latina or not
  • 46%
    Race
All 59 studies

Study titles and rules are shown in their original English.

StudyPhasepeople% women
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
NCT00000620
310,25138.6%
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial
NCT00716079
β€”2,83937.3%
Pharmacogenomic Evaluation of Antihypertensive Responses 2
NCT01203852
483951.1%
COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension
NCT00273052
356847.5%
Reducing Total Cardiovascular Risk in an Urban Community
NCT00241904
452571.2%
The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.
NCT02336607
β€”48144.7%
Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension
NCT00142584
333651.8%
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
NCT01970501
226718%
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
NCT00391846
425228.6%
Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients
NCT01213173
423167.1%
Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients
NCT00744237
423038.7%
Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients
NCT01508325
418649.5%
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM
NCT05767346
317541.7%
Black Education and Treatment of Hypertension (BEAT HTN)
NCT00661895
49972.7%
Comparison of Metoprolol and Tramadol With Remifentanil in Endoscopic Sinus Surgery
NCT02484859
48831.8%
Race, Natriuretic Peptides and Physiological Perturbations
NCT03070184
28050%
Interstitial Cystitis: Examination of the Central Autonomic Network
NCT03008382
472100%
Metoprolol to Reduce Perioperative Myocardial Injury
NCT03138603
37259.7%
Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries
NCT00829296
2/37071.4%
Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus
NCT02737891
26035%
A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement
NCT00756236
β€”6071.7%
Study to Investigate the Pharmacokinetic Profile
NCT03286829
1600%
Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate
NCT01523002
15648.2%
Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
NCT01798992
45628.6%
Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter
NCT01914926
45459.3%
The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial
NCT00605072
25358.5%
A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
NCT01324388
15135.3%
BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF
NCT04434664
45068%
Effect of Evolocumab on Coronary Atherosclerosis
NCT03689946
34712.8%
Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
NCT00775671
44665.2%
Nebivolol and Endothelial Regulation of Fibrinolysis (NERF)
NCT01595516
44436.4%
Nebivolol and the Endothelin (ET)-1 System
NCT01395329
44238.1%
Curing Atrial Fibrillation in Heart Failure
NCT00292162
β€”4122%
Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)
NCT01052428
2/33852.6%
A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate
NCT03488719
13745.9%
Open-Labeled PK-PD Studies of Metoprolol ER
NCT02417246
43647.2%
Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes
NCT00123604
43627.8%
Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life
NCT00999102
43342.4%
Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells
NCT01041287
43043.3%
Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
NCT01157234
43030%